KPBMA to Host 4th AI Drug Discovery Competition
Preliminary Round Runs Until August 7
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on June 30 that it will host the 4th Artificial Intelligence (AI) Drug Discovery Competition. The event is organized by the Ministry of Health and Welfare and co-hosted by the Korea Health Industry Development Institute, the association, Korea University College of Medicine, and Korea University College of Medicine BK21.
The theme of this year's competition is “Design and Implementation of Specialized AI Agents for Each Stage of Drug Discovery.” There are four contest categories: ▲ Autonomous Hypothesis Generation and Validation ▲ Tool Utilization-Based Molecular Optimization Loop ▲ Regulatory Compliance and Intelligent Clinical Design ▲ Convergence Fields.
The competition will select final winners through preliminary and final rounds and their respective evaluation processes. The preliminary round will run until August 7, and the final round will be held from September 7 to October 2. Any Korean citizen interested in AI drug discovery can participate as an individual or as a team of up to three members.
The grand prize includes the Minister of Health and Welfare Award and a cash prize of 10 million won. The excellence award includes the President of the Korea Health Industry Development Institute Award and a cash prize of 5 million won. The merit award consists of both the President of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association Award and the Dean of Korea University College of Medicine Award, each with a cash prize of 3 million won. The encouragement award includes the Director of the BK21 Convergence Translational Medical Science Education and Research Group at Korea University College of Medicine Award and a cash prize of 2 million won. The sponsor award will include a sponsor’s certificate and a cash prize of 1.5 million won.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The association stated, "AI technology is a key driver that enhances the efficiency of drug discovery and accelerates R&D innovation," and added, "We hope this competition will identify outstanding AI agent models that meet the needs of the drug development field and contribute to expanding the domestic AI drug discovery ecosystem."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.